Literature DB >> 24638888

Ectoenzymes in leukocyte migration and their therapeutic potential.

Marko Salmi1, Sirpa Jalkanen.   

Abstract

Inflammation causes or accompanies a huge variety of diseases. Migration of leukocytes from the blood into the tissues, in the tissues, and from the tissues to lymphatic vasculature is crucial in the formation and resolution of inflammatory infiltrates. In addition to classical adhesion and activation molecules, several other molecules are known to contribute to the leukocyte traffic. Several of them belong to ectoenzymes, which are cell surface molecules having catalytically active sites outside the cell. We will review here how several ectoenzymes present on leukocytes or endothelial cell surface function as adhesins and/or modulate the extravasation cascade through their enzymatic activities. Moreover, their therapeutic potential as immune modulators in different experimental inflammation models and in clinical trials will be discussed.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24638888     DOI: 10.1007/s00281-014-0417-9

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  150 in total

1.  Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by Ecto-5'-nucleotidase/CD73-dependent mechanism.

Authors:  Tiina Henttinen; Sirpa Jalkanen; Gennady G Yegutkin
Journal:  J Biol Chem       Date:  2003-04-21       Impact factor: 5.157

2.  CD38/CD19: a lipid raft-dependent signaling complex in human B cells.

Authors:  Silvia Deaglio; Tiziana Vaisitti; Richard Billington; Luciana Bergui; Paola Omede'; Armando A Genazzani; Fabio Malavasi
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

3.  The CD157-integrin partnership controls transendothelial migration and adhesion of human monocytes.

Authors:  Nicola Lo Buono; Rossella Parrotta; Simona Morone; Paola Bovino; Giulia Nacci; Erika Ortolan; Alberto L Horenstein; Alona Inzhutova; Enza Ferrero; Ada Funaro
Journal:  J Biol Chem       Date:  2011-04-08       Impact factor: 5.157

4.  Structural model of the catalytic domain of an enzyme with cell adhesion activity: human vascular adhesion protein-1 (HVAP-1) D4 domain is an amine oxidase.

Authors:  T A Salminen; D J Smith; S Jalkanen; M S Johnson
Journal:  Protein Eng       Date:  1998-12

5.  Different role of CD73 in leukocyte trafficking via blood and lymph vessels.

Authors:  Annika Ålgars; Marika Karikoski; Gennady G Yegutkin; Patrizia Stoitzner; Jussi Niemelä; Marko Salmi; Sirpa Jalkanen
Journal:  Blood       Date:  2011-02-23       Impact factor: 22.113

6.  Inhibition of semicarbazide-sensitive amine oxidases decreases lymphocyte infiltration in the early phases of rat liver allograft rejection.

Authors:  T Martelius; M Salmi; L Krogerus; R Loginov; M Schoultz; M Karikoski; M Miiluniemi; A Soots; K Höckerstedt; S Jalkanen; I Lautenschlager
Journal:  Int J Immunopathol Pharmacol       Date:  2008 Oct-Dec       Impact factor: 3.219

7.  Human Siglec-10 can bind to vascular adhesion protein-1 and serves as its substrate.

Authors:  Elina Kivi; Kati Elima; Kristiina Aalto; Yvonne Nymalm; Kaisa Auvinen; Erkki Koivunen; Diana M Otto; Paul R Crocker; Tiina A Salminen; Marko Salmi; Sirpa Jalkanen
Journal:  Blood       Date:  2009-10-27       Impact factor: 22.113

8.  Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration.

Authors:  Srinivas D Sithu; William R English; Paul Olson; Davia Krubasik; Andrew H Baker; Gillian Murphy; Stanley E D'Souza
Journal:  J Biol Chem       Date:  2007-06-25       Impact factor: 5.157

Review 9.  Ectoenzymes and innate immunity: the role of human CD157 in leukocyte trafficking.

Authors:  Ada Funaro; Erika Ortolan; Paola Bovino; Nicola Lo Buono; Giulia Nacci; Rossella Parrotta; Enza Ferrero; Fabio Malavasi
Journal:  Front Biosci (Landmark Ed)       Date:  2009-01-01

10.  Adenosine and prostaglandin e2 production by human inducible regulatory T cells in health and disease.

Authors:  Theresa L Whiteside; Edwin K Jackson
Journal:  Front Immunol       Date:  2013-07-25       Impact factor: 7.561

View more
  15 in total

Review 1.  How leukocytes cross the vascular endothelium.

Authors:  Dietmar Vestweber
Journal:  Nat Rev Immunol       Date:  2015-10-16       Impact factor: 53.106

Review 2.  Developing Treatments for Chronic Kidney Disease in the 21st Century.

Authors:  Matthew D Breyer; Katalin Susztak
Journal:  Semin Nephrol       Date:  2016-11       Impact factor: 5.299

3.  Introduction for the special issue on new paradigms in leukocyte trafficking, lessons for therapeutics.

Authors:  Francis W Luscinskas; Beat A Imhof
Journal:  Semin Immunopathol       Date:  2014-04-09       Impact factor: 9.623

Review 4.  Systematic Review: Targeted Molecular Imaging of Angiogenesis and Its Mediators in Rheumatoid Arthritis.

Authors:  Fatemeh Khodadust; Aiarpi Ezdoglian; Maarten M Steinz; Judy R van Beijnum; Gerben J C Zwezerijnen; Gerrit Jansen; Sander W Tas; Conny J van der Laken
Journal:  Int J Mol Sci       Date:  2022-06-25       Impact factor: 6.208

5.  Multivalent Interactions of Human Primary Amine Oxidase with the V and C22 Domains of Sialic Acid-Binding Immunoglobulin-Like Lectin-9 Regulate Its Binding and Amine Oxidase Activity.

Authors:  Heli Elovaara; Vimal Parkash; Ruth Fair-Mäkelä; Outi M H Salo-Ahen; Gabriela Guédez; Eva Bligt-Lindén; Janne Grönholm; Sirpa Jalkanen; Tiina A Salminen
Journal:  PLoS One       Date:  2016-11-28       Impact factor: 3.240

6.  Comparison of 68Ga-DOTA-Siglec-9 and 18F-Fluorodeoxyribose-Siglec-9: Inflammation Imaging and Radiation Dosimetry.

Authors:  Helena Virtanen; Johanna M U Silvola; Anu Autio; Xiang-Guo Li; Heidi Liljenbäck; Sanna Hellberg; Riikka Siitonen; Mia Ståhle; Meeri Käkelä; Anu J Airaksinen; Kerttuli Helariutta; Tuula Tolvanen; Tibor Z Veres; Antti Saraste; Juhani Knuuti; Sirpa Jalkanen; Anne Roivainen
Journal:  Contrast Media Mol Imaging       Date:  2017-12-31       Impact factor: 3.161

7.  68Ga-DOTA-Siglec-9--a new imaging tool to detect synovitis.

Authors:  Helena Virtanen; Anu Autio; Riikka Siitonen; Heidi Liljenbäck; Tiina Saanijoki; Petteri Lankinen; Jussi Mäkilä; Meeri Käkelä; Jarmo Teuho; Nina Savisto; Kimmo Jaakkola; Sirpa Jalkanen; Anne Roivainen
Journal:  Arthritis Res Ther       Date:  2015-11-03       Impact factor: 5.156

8.  Consequences of the lack of CD73 and prostatic acid phosphatase in the lymphoid organs.

Authors:  Gennady G Yegutkin; Kaisa Auvinen; Marika Karikoski; Pia Rantakari; Heidi Gerke; Kati Elima; Mikael Maksimow; Ileana B Quintero; Pirkko Vihko; Marko Salmi; Sirpa Jalkanen
Journal:  Mediators Inflamm       Date:  2014-08-24       Impact factor: 4.711

9.  Primary Amine Oxidase of Escherichia coli Is a Metabolic Enzyme that Can Use a Human Leukocyte Molecule as a Substrate.

Authors:  Heli Elovaara; Teija Huusko; Mikael Maksimow; Kati Elima; Gennady G Yegutkin; Mikael Skurnik; Ulrich Dobrindt; Anja Siitonen; Michael J McPherson; Marko Salmi; Sirpa Jalkanen
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Mapping the interaction site and effect of the Siglec-9 inflammatory biomarker on human primary amine oxidase.

Authors:  Leonor Lopes de Carvalho; Heli Elovaara; Jerôme de Ruyck; Gerard Vergoten; Sirpa Jalkanen; Gabriela Guédez; Tiina A Salminen
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.